A Prospective Clinical Study Assessing the Effects of Tetracycline Antibiotic on Tear Film and Tear Lipid Composition Within a Population of Patients Diagnosed With Blepharitis and Dry Eye Disease
NCT00355459 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2018-12-13
Summary
The purpose of this research project is to determine the effects of oral tetracycline such as Minocycline (Minocin) on tear film composition and tear lipid (meibomian gland secretions) characteristics in patients with chronic Blepharitis and associated dry eyes.
Conditions
- Dry Eye Syndrome
Interventions
- DRUG
-
Tetracycline: Doxycycline analog
Sponsors & Collaborators
-
University of Texas Southwestern Medical Center
lead OTHER
Principal Investigators
-
James P. McCulley, M.D. · University of Texas, Southwestern Medical Center at Dallas
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 88 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2005-08-31
- Completion
- 2007-04-30
Countries
- United States
Study Locations
More Related Trials
-
Tear Film Stability and Improvement of Asthenopia: Efficacy Observation of 0.05% Cyclosporine in Dry Eye Patients With Short BUT
NCT06981104 ·Status: COMPLETED ·Phase: NA
-
Comparing Efficacy of Tea Tree Oil Versus Topical Azithromycin in Treating Dry Eye
NCT06921525 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Effect of Controlled Adverse Environment (CAE) on Tear Film Stability
NCT01547936 ·Status: COMPLETED
-
Study of the Effect of Diquafosol Tetrasodium Ophthalmic Solution, 2% Versus Placebo in Dry Eye Subjects (P08634)
NCT00600288 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease
NCT02229955 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison Between Continuous and Pulsed Oral Doxycycline Treatment Protocols for Refractory Meibomian Gland Dysfunction
NCT06520007 ·Status: COMPLETED
-
Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis
NCT00884585 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Systane Versus Saline in Maintaining Tear Film Stability at Determined Time Points
NCT00345241 ·Status: COMPLETED ·Phase: NA
-
The Effect of 0.1% Topical Ciclosporin A for 12-weeks on the Eye Surface Immune Cells in Dry Eyes
NCT06898853 ·Status: RECRUITING ·Phase: NA
-
Eyelid Androgen Treatment in Dry Eye
NCT06154200 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of a New Multi-dose Lubricant Eye Drop Concomitant With Restasis® (Cyclosporine A) for the Treatment of Dry Eye Symptoms
NCT00405457 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of TL-925 as a Treatment for Dry Eye Disease
NCT05745064 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients
NCT05245604 ·Status: UNKNOWN ·Phase: PHASE3
-
Study of the TearCare System in Dry Eye Disease
NCT03588624 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
NCT05119920 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease
NCT06824844 ·Status: COMPLETED ·Phase: PHASE4
-
Azithromycin Level in Tears and in Conjunctiva in 36 Healthy Volunteers
NCT00356772 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Evaluation of Tavilermide Ophthalmic Solution for the Treatment of Dry Eye
NCT05848128 ·Status: COMPLETED ·Phase: PHASE3
-
Systemic Pharmacokinetics of BOL-303224-A
NCT00407589 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
Study of DE-089 Ophthalmic Solution in Patients With Dry Eye
NCT01101984 ·Status: COMPLETED ·Phase: NA
-
Tear Film Break-up Time After Instillation of Artificial Tears
NCT00681265 ·Status: COMPLETED ·Phase: NA
-
The Effects and Safety of Topical Spironolactone Ophthalmic Solution, 0.005 mg/cc in Subjects With Dry Eye Disease
NCT05995392 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
TearLab Core Validation Study to Establish Referent Values for Dry Eye Disease
NCT00848198 ·Status: COMPLETED